Literature DB >> 9764995

Time course of cell cycle-related protein expression in diethylnitrosamine-initiated rat liver.

Y S Lee1, W H Kim, E S Yu, M R Kim, M J Lee, J J Jang.   

Abstract

BACKGROUND/AIMS: Cell cycle control and the relationship that exists between cellular proliferation, the expression of cell cycle control proteins and cancer have been reported. This study was designed to decipher the timing of cell cycle control protein expression during the initiation of diethylnitrosamine-induced rat hepatocarcinogenesis.
METHODS: Three-week-old female Sprague-Dawley rats were intraperitoneally injected twice in 1 week with diethylnitrosamine; after the second injection, all animals were sacrificed at 1, 2 and 24 h, and 3 and 7 days. The expression of cell cycle-related proteins such as CDK2 and 4, cyclin proteins (D1, E and cdc2), proliferating cell nuclear antigen, tumor suppressor proteins (p53 and Rb), CDK inhibitory proteins (p21waf1 and p27Kip1), and apoptosis-inhibiting protein (bcl-2) following diethylnitrosamine treatment was examined.
RESULTS: The peak induction time of each cell cycle-related protein during DEN-induced cellular proliferation was diverse, and expressions of CDK2, CDK4, cdc2, p53, bcl-2, p21Waf1 and p27Kip1 appear to be of the greatest interest.
CONCLUSIONS: Data generated from this study may provide information about cell cycle-related protein expression in the initiation stage of hepatocarcinogenic signaling pathways stimulated by a genotoxic agent such as diethylnitrosamine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9764995     DOI: 10.1016/s0168-8278(98)80066-4

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  1 in total

1.  Preventive Effects of Vitamin C on Diethylnitrosamine-induced Hepatotoxicity in Smp30 Knockout Mice.

Authors:  Young-Sook Son; H M Arif Ullah; Ahmed K Elfadl; Myung-Jin Chung; Soong-Gu Ghim; Yong Deuk Kim; Eun-Joo Lee; Kyung-Ku Kang; Kyu-Shik Jeong
Journal:  In Vivo       Date:  2018 Jan-Feb       Impact factor: 2.155

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.